» Articles » PMID: 37112869

The Omicron Lineages BA.1 and BA.2 ( SARS-CoV-2) Have Repeatedly Entered Brazil Through a Single Dispersal Hub

Abstract

Brazil currently ranks second in absolute deaths by COVID-19, even though most of its population has completed the vaccination protocol. With the introduction of Omicron in late 2021, the number of COVID-19 cases soared once again in the country. We investigated in this work how lineages BA.1 and BA.2 entered and spread in the country by sequencing 2173 new SARS-CoV-2 genomes collected between October 2021 and April 2022 and analyzing them in addition to more than 18,000 publicly available sequences with phylodynamic methods. We registered that Omicron was present in Brazil as early as 16 November 2021 and by January 2022 was already more than 99% of samples. More importantly, we detected that Omicron has been mostly imported through the state of São Paulo, which in turn dispersed the lineages to other states and regions of Brazil. This knowledge can be used to implement more efficient non-pharmaceutical interventions against the introduction of new SARS-CoV variants focused on surveillance of airports and ground transportation.

Citing Articles

Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022-2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts.

Souza U, Spilki F, Tanuri A, Roehe P, Campos F Viruses. 2025; 17(1).

PMID: 39861853 PMC: 11768930. DOI: 10.3390/v17010064.


Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.

Cavalcante F, Martin C, Frio G, Stabeli R, Santos L PLOS Glob Public Health. 2025; 5(1):e0003289.

PMID: 39787152 PMC: 11717220. DOI: 10.1371/journal.pgph.0003289.


Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification.

Fonseca P, Braga-Paz I, de Araujo E Santos L, Dias R, de Souza C, Carvalho N Microorganisms. 2024; 12(9).

PMID: 39338420 PMC: 11434267. DOI: 10.3390/microorganisms12091745.


Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol.

Campos G, Almeida N, Filgueiras P, Corsini C, Gomes S, de Miranda D Front Cell Infect Microbiol. 2024; 14:1371695.

PMID: 38638823 PMC: 11024236. DOI: 10.3389/fcimb.2024.1371695.


Epidemiology of the SARS-CoV-2 Omicron Variant Emergence in the Southeast Brazilian Population.

Rodrigues E, Slavov S, de La Roque D, Santos E, Borges J, Evaristo M Microorganisms. 2024; 12(3).

PMID: 38543500 PMC: 10974166. DOI: 10.3390/microorganisms12030449.


References
1.
Yong S, Liu S . Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2021; 32(4):e2315. DOI: 10.1002/rmv.2315. View

2.
Rahimi F, Talebi Bezmin Abadi A . Is Omicron the last SARS-CoV-2 Variant of Concern?. Arch Med Res. 2022; 53(3):336-338. PMC: 8768426. DOI: 10.1016/j.arcmed.2022.01.001. View

3.
Hadfield J, Megill C, Bell S, Huddleston J, Potter B, Callender C . Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018; 34(23):4121-4123. PMC: 6247931. DOI: 10.1093/bioinformatics/bty407. View

4.
Fonseca P, Moreira F, de Souza R, Guimaraes N, Carvalho N, Adelino T . Tracking the turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian state (Minas Gerais) with a high-vaccination status. Virus Evol. 2022; 8(2):veac064. PMC: 9384558. DOI: 10.1093/ve/veac064. View

5.
Candido D, Claro I, de Jesus J, Souza W, Moreira F, Dellicour S . Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020; 369(6508):1255-1260. PMC: 7402630. DOI: 10.1126/science.abd2161. View